HomeSUPN • NASDAQ
Supernus Pharmaceuticals Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 165.45M | -1.71% |
Operating expense | 137.49M | 4.00% |
Net income | 22.50M | 12.97% |
Net profit margin | 13.60 | 14.96% |
Earnings per share | 0.91 | 35.46% |
EBITDA | 32.50M | -16.52% |
Effective tax rate | -34.98% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 522.60M | 50.52% |
Total assets | 1.38B | 5.06% |
Total liabilities | 318.51M | -11.13% |
Total equity | 1.06B | — |
Shares outstanding | 56.07M | — |
Price to book | 2.18 | — |
Return on assets | 2.04% | — |
Return on capital | 2.58% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 22.50M | 12.97% |
Cash from operations | 58.54M | 64.31% |
Cash from investing | -30.61M | 37.01% |
Cash from financing | 935.00K | -43.61% |
Net change in cash | 28.86M | 355.15% |
Free cash flow | 46.23M | 32.42% |
Previous close
$41.24
Day range
$41.01 - $42.84
Year range
$29.16 - $43.62
Market cap
2.39B USD
Avg Volume
931.93K
P/E ratio
37.30
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Headquarters
Website
Employees
674
